FDA Issues Emergency Use

FDA Issues Emergency Use is projected to open between ₹9 crore and ₹17 crore, with a midpoint estimate of ₹12 crore, though confidence in this forecast is low due to incomplete data on the cast's box office draw and audience buzz levels. The wide prediction range reflects significant uncertainty around the film's commercial appeal, as key performance indicators including star power metrics and pre-release social engagement data are currently unavailable.